Home » Topics » Regulatory

Regulatory
RSS

FDA approves Tremfya for moderate to severe plaque psoriasis

July 14, 2017

Korea first to approve Invossa-K cell and gene therapy for degenerative arthritis

July 13, 2017

FDA approves Endari for sickle cell disease

July 10, 2017

Amenalief approved in Japan to treat herpes zoster

July 5, 2017

Mitsubishi Tanabe Pharma obtains approval in Japan for Canalia combination tablets

July 4, 2017

European Commission approves Pfizer's inotuzumab ozogamicin

July 3, 2017

FDA approves Bevyxxa for hospital and extended-duration prophylaxis of VTE

June 26, 2017

FDA approves Baxdela for ABSSSI

June 20, 2017

FDA approves first topical ocular formulation of cetirizine

June 1, 2017

FDA approves Novo Nordisk's Rebinyn for hemophilia B

June 1, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...